SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma informs about Financial Results

12 May 2015 Evaluate

Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 22, 2015, to consider the approval of the unaudited financial Results for the quarter ending March, 2015 along with Audited Annual Accounts for the year 2014-2015, approval of increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc. Further issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional Placement (QIP) to Foreign Institutional Investors (FIIs), Qualified Institutional Buyers or any other investors etc, Merger of Natco Organics (100% subsidiary Company) into Natco Pharma, Consideration of Employee Stock Option Scheme under SEBI (Share Based Employee Benefits) Regulations, 2014 and Convening of Extraordinary General Meeting of the Members. Further, TRADING WINDOW for dealing in the securities of the Company will be closed from May 12, 2015 to May 24, 2015. Trading window will be opened from May 25, 2015.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1174.00 19.80 (1.72%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×